The outcomes presented that the top 5 mutational frequency of SPOP mutation arise in endometrial cancer, breast carcinoma, embryonal cancer, pancreatic cancer, and prostate cancer (Fig 4C). This evidence concerns the gene SPOP and pancreatic neoplasm.